Tariq Kewan

881 total citations
70 papers, 407 citations indexed

About

Tariq Kewan is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tariq Kewan has authored 70 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 22 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Tariq Kewan's work include Acute Myeloid Leukemia Research (31 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Lymphoma Diagnosis and Treatment (8 papers). Tariq Kewan is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Lymphoma Diagnosis and Treatment (8 papers). Tariq Kewan collaborates with scholars based in United States, Italy and Jordan. Tariq Kewan's co-authors include Mohammed Al‐Jaghbeer, Fahrettin Covut, K V Gopalakrishna, Hamed Daw, Abdo Haddad, Waled Bahaj, Jaroslaw P. Maciejewski, Valeria Visconte, Abdel‐Hameed Al‐Mistarehi and Carmelo Gurnari and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tariq Kewan

53 papers receiving 401 citations

Peers

Tariq Kewan

NEURO

HEMAT

ONCOL

Hervé Lobbes France

Tarik Hadid United States

Nilgün Sayınalp Türkiye

Inga Hegemann Switzerland

Massimiliano Monticelli Italy

Emmanuelle Jeanpierre France

Jens Helby Denmark

Ding Long China

Lale Olcay Türkiye

Jennifer L. Pauley United States

Hervé Lobbes France

Tariq Kewan

164 ×1.0

63 ×0.5

NEURO

66 ×0.6

HEMAT

62 ×0.9

ONCOL

22 ×0.4

Citations per year, relative to Tariq Kewan Tariq Kewan (= 1×) peers Hervé Lobbes

Countries citing papers authored by Tariq Kewan

Since Specialization

Citations

This map shows the geographic impact of Tariq Kewan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tariq Kewan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tariq Kewan more than expected).

Fields of papers citing papers by Tariq Kewan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tariq Kewan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tariq Kewan. The network helps show where Tariq Kewan may publish in the future.

Co-authorship network of co-authors of Tariq Kewan

This figure shows the co-authorship network connecting the top 25 collaborators of Tariq Kewan. A scholar is included among the top collaborators of Tariq Kewan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tariq Kewan. Tariq Kewan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aly, Mai, Tariq Kewan, Waled Bahaj, et al.. (2025). Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia: A Real-World Experience. Cancers. 17(6). 1020–1020. 2 indexed citations

Kewan, Tariq, et al.. (2025). Advances and Challenges in the Management of Myelodysplastic Syndromes. Cancers. 17(15). 2469–2469.

Grimshaw, Alyssa, Jan Philipp Bewersdorf, Tariq Kewan, et al.. (2024). Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database. JCO Global Oncology. 10(10). e2400316–e2400316. 2 indexed citations

Kewan, Tariq, et al.. (2024). Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities. Current Hematologic Malignancy Reports. 19(3). 138–150.

Bewersdorf, Jan Philipp, et al.. (2024). Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them. Cancers. 16(23). 4092–4092.

Kewan, Tariq, Arda Durmaz, Waled Bahaj, et al.. (2024). Clinical and Molecular Insights into the Classification Dilemma: Are MDS/AML Cases Distinct from Secondary AML?. Blood. 144(Supplement 1). 850–850. 1 indexed citations

Kewan, Tariq, Waled Bahaj, Arda Durmaz, et al.. (2023). Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes. Blood. 141(14). 1768–1772. 18 indexed citations

Mori, Minako, Yasuo Kubota, Arda Durmaz, et al.. (2023). Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets. Leukemia. 37(10). 2082–2093. 10 indexed citations

Bahaj, Waled, Tariq Kewan, Danai Dima, et al.. (2023). Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response. Journal of Internal Medicine. 295(2). 229–241. 2 indexed citations

10.

Bahaj, Waled, Tariq Kewan, Carmelo Gurnari, et al.. (2023). Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia. Journal of Hematology & Oncology. 16(1). 91–91. 14 indexed citations

11.

Kewan, Tariq, et al.. (2021). Prognostic impact and risk factors of cancer‐associated thrombosis events in stage‐IV cancer patients treated with immune checkpoint inhibitors. European Journal Of Haematology. 106(5). 682–688. 21 indexed citations

12.

Samrah, Shaher, et al.. (2021). Viral Clearance Course of COVID-19 Outbreaks. Journal of Multidisciplinary Healthcare. Volume 14. 555–565. 15 indexed citations

13.

Kewan, Tariq, et al.. (2021). Characteristics and outcomes of adverse events after COVID‐19 vaccination. SHILAP Revista de lepidopterología. 2(5). e12565–e12565. 15 indexed citations

14.

Kewan, Tariq, et al.. (2020). A Rare Case of ST-elevation Myocardial Infarction After Blunt Chest Trauma. Cureus. 12(4). e7710–e7710. 2 indexed citations

15.

Abdo, Nour, et al.. (2020). LTA, LEP, and TNF-a Gene Polymorphisms are Associated with Susceptibility and Overall Survival of Diffuse Large B-Cell lymphoma in an Arab Population: A Case-Control Study. Asian Pacific Journal of Cancer Prevention. 21(9). 2783–2791. 8 indexed citations

16.

Kewan, Tariq, et al.. (2020). Does inpatient hyperglycemia predict a worse outcome in COVID‐19 intensive care unit patients?. Journal of Diabetes. 13(3). 253–260. 35 indexed citations

17.

Kewan, Tariq, et al.. (2019). Scurvy: A Rare Cause of Anemia. Cureus. 11(9). e5694–e5694. 2 indexed citations

18.

Kewan, Tariq, et al.. (2018). Late Central Nervous System Relapse in a Patient with Maxillary Sinus Lymphoma. Cureus. 10(12). e3745–e3745.

19.

Kewan, Tariq, et al.. (2017). Risk Factors of Central Nervous System Involvement in Diffuse Large B-Cell Lymphoma Patients: Single Center Experience. Blood. 130. 5227–5227. 1 indexed citations

20.

Kewan, Tariq, et al.. (2017). Alkaline Phosphatase Serum Level at Time of Diagnosis Is a Prognostic Marker in Patients with Hodgkin Lymphoma. Blood. 130. 5187–5187. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact